## Abstract Amyloids are proteinaceous aggregates related to the soβcalled conformational diseases, such as Alzheimer's and prion diseases. The cytotoxicity of amyloids may be related to the interaction of the amiloidogenic peptides or proteins with the cell membrane. In order to gain information o
Prion protein fragment interacts with PrP-deficient cells
β Scribed by David R. Brown; Bernhard Schmidt; Hans A. Kretzschmar
- Book ID
- 101245566
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 138 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
β¦ Synopsis
A fragment of the prion protein (PrP106-126) induces cell death in cultures of wild-type embryonic day (E)16 mouse cortical neurons but not cells derived from mice devoid of cellular PrP(PrP o/o) . Two common binding partners for PrP106-126 expressed in both wild-type and PrP o/o mouse brain were isolated and their sequences determined. The two proteins were found to be β£ and β€ tubulin. Further evidence that tubulin binds PrP106-126 within cells comes from cell culture experiments. Colchicine toxicity on PrP o/o mouse cortical cells is enhanced by PrP106-126 and taxol enhances toxicity of PrP106-126 on wild-type mouse cortical cells. Our evidence shows that a fragment of PrP can bind a cellular protein and in so doing, alters the metabolism of cells even when they do not express native PrP. This indicates that PrP106-126 is nontoxic to PrP o/o cells, not because of an inability to interact with these cells but because of the loss of some aspect of a PrP expression-dependent phenotype.
π SIMILAR VOLUMES
## Abstract Prion diseases are neurodegenerative disorders that are characterized by the presence of the misfolded prion protein (PrP). Neurotoxicity in these diseases may result from prionβinduced modulation of ion channel function, changes in neuronal excitability, and consequent disruption of ce